MAPT and Alzheimer disease: To ensure that our consecutive immuno-/Thio-S staining procedure detects pathologically aggregated protein deposits, we confirmed presence of doubly labeled deposits (amyloid beta and tau) in brain sections of two models of Alzheimer’s disease (Figure S7; bottom two rows).